Eli Lilly Investor
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Technology:
Biotechnology, Cell_Therapies, Health Care, Medical, Pharmaceutical
Industry:
AI, Pharma
Headquarters:
Indianapolis, Indiana, United States
Zip:
10001+
Founded Date:
1876-01-01
Employees Number:
10001+
Funding Status:
Public Company
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
18
Acquisitions Number:
27
Investors Number:
NA
Total Funding:
$1B to $10B
Estimated Revenue:
$1B to $10B
Last Funding Date:
2013-09-26
Register and Claim Ownership
Suggested by